Quest PharmaTech Inc.
QPTFF
$0.0133
-$0.0017-11.33%
OTC PK
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.86% | 133.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 36.97% | 54.53% | |||
| Operating Income | -36.97% | -54.53% | |||
| Income Before Tax | -95.17% | 182.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -95.17% | 182.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -95.17% | 182.78% | |||
| EBIT | -36.97% | -54.53% | |||
| EBITDA | -37.03% | -55.04% | |||
| EPS Basic | -93.55% | 181.58% | |||
| Normalized Basic EPS | -177.78% | 140.91% | |||
| EPS Diluted | -93.55% | 181.58% | |||
| Normalized Diluted EPS | -177.78% | 140.91% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||